FDA Approves Novolog Mix 50/50

FDA Approves Novolog Mix 50/50

The FDA has approved Novo Nordisk's Novolog Mix 50/50 (50% insulin aspart protamine suspension and 50% insulin aspart injection, [rDNA origin]). Novolog Mix 50/50 is indicated as an adjunct to diet and exercise to improve glycemic control in patients with diabetes mellitus.

Posted: August 2008

Comments

(web5)